Swedish Orphan Biovitrum Publishes Report for the First Quarter 2013
4/26/2013 11:14:12 AM
More...
|
Swedish Orphan Biovitrum Appoints Mats-Olof Wallin as Interim Chief Financial Officer
4/8/2013 9:20:07 AM
More...
|
Swedish Orphan Biovitrum Publishes Annual Report
4/5/2013 9:20:44 AM
More...
|
Exelixis, Inc. (EXEL) Selects Swedish Orphan Biovitrum as COMETRIQ™ European Distributor for Medullary Thyroid Cancer
2/22/2013 10:08:51 AM
More...
|
Swedish Orphan Biovitrum Gains Distribution Rights for Megace®, Monopril®, Cefzil®; and Duricef®; From PharmaSwiss
2/13/2013 10:00:36 AM
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: New Phase 3 Data Reinforce Long-Lasting Protection From Bleeding for Patients With Hemophilia A and B
2/8/2013 9:47:43 AM
More...
|
FDA Approves Swedish Orphan Biovitrum's Kineret for the Treatment of NOMID
1/8/2013 8:04:33 AM
More...
|
Swedish Orphan Biovitrum Files to Expand Kineret® Label to Include CAPS
11/19/2012 9:28:50 AM
More...
|
Swedish Orphan Biovitrum Enters Research Collaboration With Affibody Within the IL-1 Field
7/10/2012 8:17:18 AM
More...
|
Swedish Orphan Biovitrum Files for NOMID Indication for Kineret in US
7/6/2012 9:26:21 AM
More...
|
|